Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Clinical trial NCT06783153 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06783153
Sponsor: Mansoura University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Radiotherapy Induced Diarrhea Acute Radiation Enteritis Prostate Cancer Cervical Adenocarcinoma Bladder (Urothelial, Transitional Cell) Cancer Rectal Adenocarcinoma Pelvic Radiotherapy Rifaximin

Start date: 2025-01-20
Primary completion: 2025-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.